Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "191.45",
    "chg": 2.78,
    "chgp": "1.47%",
    "dir": 1,
    "prev_price": "188.67",
    "mcapval": "657.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE729D01010",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "06:46 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "14.97 k",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs Gains 6.57%: 3 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-657-3-key-factors-driving-the-weeks-rally-4192195",
        "imagepath": "",
        "date": "2026-09-13 14:00:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Stock opens week with a 3.55% gain to ₹175.00</p>\n                    <p><strong>1 Sep:</strong> Valuation shifts to fair amid sector comparisons</p>\n                    <p><strong>2 Sep:</strong> Technical momentum turns mildly bearish with mixed signals</p>\n                    <p><strong>4 Sep:</strong> Stock surges to upper circuit, closing at ₹180.10 (+4.98%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹169.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹180...."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-sell-4187722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_mojoScore_4187722.png",
        "date": "2026-09-09 10:11:39",
        "description": "Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4184412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_technicaldot_4184412.png",
        "date": "2026-09-07 08:00:31",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its price momentum, moving from a mildly bearish to a mildly bullish technical trend. Despite a recent downgrade in its Mojo Grade to Sell from Hold, the stock’s technical indicators present a complex picture, with some signals suggesting potential upside while others remain cautious. This article analyses the latest technical parameters, price movements, and relative performance against the Sensex to provide a comprehensive view for investors."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-4182803",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_stocks_hitting_upper_circuit_4182803.png",
        "date": "2026-09-04 15:00:09",
        "description": "At Rs 181.14, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 4 Sep 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4178389",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_technicaldot_4178389.png",
        "date": "2026-09-02 08:01:06",
        "description": "Kilitch Drugs (India) Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook. Despite a modest decline in price and a downgrade in its Mojo Grade to Sell, the stock’s long-term returns remain impressive compared to the broader market, signalling a complex technical and fundamental landscape for investors to navigate."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts to Fair Amidst Sector Comparisons and Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-fair-amidst-sector-comparisons-and-market-performance-4176577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KilitchDrugsInd_valuationdot_4176577.png",
        "date": "2026-09-01 08:00:08",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a previously very attractive rating to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now aligning more closely with sector peers. Investors should carefully analyse these valuation adjustments in the context of Kilitch’s financial performance and broader industry trends."
      },
      {
        "title": "Kilitch Drugs Gains 4.32%: Valuation Shift and Downgrade Shape Weekly Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-gains-432-valuation-shift-and-downgrade-shape-weekly-moves-4175087",
        "imagepath": "",
        "date": "2026-08-30 14:01:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>24 Aug:</strong> Stock rallies 3.52% amid positive volume</p>\n                    <p><strong>25 Aug:</strong> Further 2.92% gain despite Sensex rise; Mojo Grade downgraded to Sell</p>\n                    <p><strong>26 Aug:</strong> Valuation shifts to fair; stock dips marginally -0.17%</p>\n                    <p><strong>27-28 Aug:</strong> Price retreats 1.92% over two days amid subdued volumes</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.162.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"..."
      },
      {
        "title": "Kilitch Drugs Downgraded to Sell Amid Valuation and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-downgraded-to-sell-amid-valuation-and-financial-concerns-4169366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KilitchDrugsInd_mojoScore_4169366.png",
        "date": "2026-08-26 08:01:34",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by a reassessment of its valuation metrics and recent financial performance. Despite some long-term growth indicators, the company’s current fundamentals and market positioning have raised concerns among analysts, prompting a revision of its overall mojo score to 47.0, classified as a Sell."
      },
      {
        "title": "Kilitch Drugs Valuation Shifts to Fair Amidst Mixed Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-valuation-shifts-to-fair-amidst-mixed-market-performance-4169271",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KilitchDrugsInd_valuationdot_4169271.png",
        "date": "2026-08-26 08:00:11",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade as of 25 August 2026. This change reflects evolving market perceptions amid sector-wide valuation trends and peer comparisons within the Pharmaceuticals & Biotechnology industry. Investors should carefully analyse the implications of these adjustments on the stock’s price attractiveness and future potential."
      }
    ],
    "total": 371,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated December 09, 2019, titled \"Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn\".",
      "source": "NSE",
      "caption": "Kilitch Drugs (India) Limited - Press Release",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Kilitch Drugs (India) Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on September 19, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "19-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Mar 26",
          "dt": "2026-03-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs Gains 6.57%: 3 Key Factors Driving the Week’s Rally

2026-09-13 14:00:42

Key Events This Week

31 Aug: Stock opens week with a 3.55% gain to ₹175.00

1 Sep: Valuation shifts to fair amid sector comparisons

2 Sep: Technical momentum turns mildly bearish with mixed signals

4 Sep: Stock surges to upper circuit, closing at ₹180.10 (+4.98%)

Week Open

₹169.00

Week Close

₹180....

Read full news article

Kilitch Drugs (India) Ltd is Rated Sell

2026-09-09 10:11:39

Kilitch Drugs (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-07 08:00:31

Kilitch Drugs (India) Ltd has experienced a notable shift in its price momentum, moving from a mildly bearish to a mildly bullish technical trend. Despite a recent downgrade in its Mojo Grade to Sell from Hold, the stock’s technical indicators present a complex picture, with some signals suggesting potential upside while others remain cautious. This article analyses the latest technical parameters, price movements, and relative performance against the Sensex to provide a comprehensive view for investors.

Read full news article

Kilitch Drugs (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-09-04 15:00:09

At Rs 181.14, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Kilitch Drugs (India) Ltd locked at its upper circuit of 5% on 4 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-02 08:01:06

Kilitch Drugs (India) Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish stance to a mildly bearish outlook. Despite a modest decline in price and a downgrade in its Mojo Grade to Sell, the stock’s long-term returns remain impressive compared to the broader market, signalling a complex technical and fundamental landscape for investors to navigate.

Read full news article

Kilitch Drugs Valuation Shifts to Fair Amidst Sector Comparisons and Market Performance

2026-09-01 08:00:08

Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a previously very attractive rating to a fair valuation grade. This change reflects evolving market perceptions amid a competitive pharmaceutical sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now aligning more closely with sector peers. Investors should carefully analyse these valuation adjustments in the context of Kilitch’s financial performance and broader industry trends.

Read full news article

Kilitch Drugs Gains 4.32%: Valuation Shift and Downgrade Shape Weekly Moves

2026-08-30 14:01:01

Key Events This Week

24 Aug: Stock rallies 3.52% amid positive volume

25 Aug: Further 2.92% gain despite Sensex rise; Mojo Grade downgraded to Sell

26 Aug: Valuation shifts to fair; stock dips marginally -0.17%

27-28 Aug: Price retreats 1.92% over two days amid subdued volumes

Week Open

Rs.162.00

Week Close

Read full news article

Kilitch Drugs Downgraded to Sell Amid Valuation and Financial Concerns

2026-08-26 08:01:34

Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by a reassessment of its valuation metrics and recent financial performance. Despite some long-term growth indicators, the company’s current fundamentals and market positioning have raised concerns among analysts, prompting a revision of its overall mojo score to 47.0, classified as a Sell.

Read full news article

Kilitch Drugs Valuation Shifts to Fair Amidst Mixed Market Performance

2026-08-26 08:00:11

Kilitch Drugs (India) Ltd has experienced a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade as of 25 August 2026. This change reflects evolving market perceptions amid sector-wide valuation trends and peer comparisons within the Pharmaceuticals & Biotechnology industry. Investors should carefully analyse the implications of these adjustments on the stock’s price attractiveness and future potential.

Read full news article

View All News